Published in Pediatr Blood Cancer on April 29, 2013
ATR phosphorylates SMARCAL1 to prevent replication fork collapse. Genes Dev (2013) 1.70
Identification and characterization of SMARCAL1 protein complexes. PLoS One (2013) 0.93
High-affinity DNA-binding domains of replication protein A (RPA) direct SMARCAL1-dependent replication fork remodeling. J Biol Chem (2014) 0.90
A structure-specific nucleic acid-binding domain conserved among DNA repair proteins. Proc Natl Acad Sci U S A (2014) 0.84
Novel SMARCAL1 bi-allelic mutations associated with a chromosomal breakage phenotype in a severe SIOD patient. J Clin Immunol (2013) 0.81
SMARCAL1 maintains telomere integrity during DNA replication. Proc Natl Acad Sci U S A (2015) 0.81
Phosphorylation of a C-terminal auto-inhibitory domain increases SMARCAL1 activity. Nucleic Acids Res (2013) 0.79
A novel splice site mutation in SMARCAL1 results in aberrant exon definition in a child with schimke immunoosseous dysplasia. Am J Med Genet A (2015) 0.77
Identification of a Substrate Recognition Domain in the Replication Stress Response Protein Zinc Finger Ran-binding Domain-containing Protein 3 (ZRANB3). J Biol Chem (2016) 0.77
RecG controls DNA amplification at double-strand breaks and arrested replication forks. FEBS Lett (2017) 0.75
Novel mutations target distinct subgroups of medulloblastoma. Nature (2012) 4.82
Identification of multiple distinct Snf2 subfamilies with conserved structural motifs. Nucleic Acids Res (2006) 4.64
The Bloom's syndrome helicase can promote the regression of a model replication fork. J Biol Chem (2006) 2.65
Mutant chromatin remodeling protein SMARCAL1 causes Schimke immuno-osseous dysplasia. Nat Genet (2002) 2.64
HARP is an ATP-driven annealing helicase. Science (2008) 2.54
The annealing helicase SMARCAL1 maintains genome integrity at stalled replication forks. Genes Dev (2009) 2.50
The SIOD disorder protein SMARCAL1 is an RPA-interacting protein involved in replication fork restart. Genes Dev (2009) 2.44
Loss of BRG1/BRM in human lung cancer cell lines and primary lung cancers: correlation with poor prognosis. Cancer Res (2003) 2.28
The annealing helicase HARP protects stalled replication forks. Genes Dev (2009) 2.19
The annealing helicase HARP is recruited to DNA repair sites via an interaction with RPA. Genes Dev (2009) 1.96
SMARCAL1 catalyzes fork regression and Holliday junction migration to maintain genome stability during DNA replication. Genes Dev (2012) 1.85
Manifestations and treatment of Schimke immuno-osseous dysplasia: 14 new cases and a review of the literature. Eur J Pediatr (2000) 1.48
Schimke immunoosseous dysplasia: suggestions of genetic diversity. Hum Mutat (2007) 1.19
Penetrance of biallelic SMARCAL1 mutations is associated with environmental and genetic disturbances of gene expression. Hum Mol Genet (2012) 1.18
The Werner and Bloom syndrome proteins help resolve replication blockage by converting (regressed) holliday junctions to functional replication forks. Biochemistry (2011) 1.11
Longevity in Schimke immuno-osseous dysplasia. J Med Genet (2002) 1.03
SMARCAL1 deficiency predisposes to non-Hodgkin lymphoma and hypersensitivity to genotoxic agents in vivo. Am J Med Genet A (2012) 1.01
SMARCAL1 and replication stress: an explanation for SIOD? Nucleus (2010) 1.01
Dental abnormalities in Schimke immuno-osseous dysplasia. J Dent Res (2012) 0.95
RAPADILINO RECQL4 mutant protein lacks helicase and ATPase activity. Biochim Biophys Acta (2012) 0.91
R561C missense mutation in the SMARCAL1 gene associated with mild Schimke immuno-osseous dysplasia. Pediatr Nephrol (2005) 0.87
Squamous cell carcinoma of the tongue in a patient with Rothmund-Thomson syndrome. Br J Plast Surg (1998) 0.87
Schimke-immuno-osseous dysplasia: new mutation with weak genotype-phenotype correlation in siblings. Am J Med Genet A (2005) 0.86
Rituximab resistant evans syndrome and autoimmunity in Schimke immuno-osseous dysplasia. Pediatr Rheumatol Online J (2011) 0.86
Cerebellar atrophy in Schimke-immuno-osseous dysplasia. Am J Med Genet A (2007) 0.84
Molecular assessment of thymic capacities in patients with Schimke immuno-osseous dysplasia. Clin Immunol (2009) 0.80
Combined modality treatment for locally advanced squamous-cell carcinoma of the oropharynx in a woman with Bloom's syndrome: a case report and review of the literature. Ann Oncol (2001) 0.78
Bladder carcinoma with Werner syndrome. Urology (1987) 0.78
ATR: an essential regulator of genome integrity. Nat Rev Mol Cell Biol (2008) 11.86
Regulation of ATR substrate selection by Rad17-dependent loading of Rad9 complexes onto chromatin. Genes Dev (2002) 4.58
ATRIP binding to replication protein A-single-stranded DNA promotes ATR-ATRIP localization but is dispensable for Chk1 phosphorylation. Mol Biol Cell (2005) 3.08
TopBP1 activates ATR through ATRIP and a PIKK regulatory domain. Genes Dev (2008) 2.86
Rapid activation of ATR by ionizing radiation requires ATM and Mre11. J Biol Chem (2006) 2.76
Deletion of histone deacetylase 3 reveals critical roles in S phase progression and DNA damage control. Mol Cell (2008) 2.71
The annealing helicase SMARCAL1 maintains genome integrity at stalled replication forks. Genes Dev (2009) 2.50
Analysis of protein dynamics at active, stalled, and collapsed replication forks. Genes Dev (2011) 2.47
ATR signalling: more than meeting at the fork. Biochem J (2011) 2.37
The basic cleft of RPA70N binds multiple checkpoint proteins, including RAD9, to regulate ATR signaling. Mol Cell Biol (2008) 2.17
Function of a conserved checkpoint recruitment domain in ATRIP proteins. Mol Cell Biol (2007) 2.02
Evaluation of HLA matching in unrelated hematopoietic stem cell transplantation for nonmalignant disorders. Blood (2012) 1.86
SMARCAL1 catalyzes fork regression and Holliday junction migration to maintain genome stability during DNA replication. Genes Dev (2012) 1.85
DDB1 maintains genome integrity through regulation of Cdt1. Mol Cell Biol (2006) 1.84
Common mechanisms of PIKK regulation. DNA Repair (Amst) (2009) 1.73
ATR phosphorylates SMARCAL1 to prevent replication fork collapse. Genes Dev (2013) 1.70
Risk factors for acute graft-versus-host disease after human leukocyte antigen-identical sibling transplants for adults with leukemia. J Clin Oncol (2008) 1.63
Dpb11 activates the Mec1-Ddc2 complex. Proc Natl Acad Sci U S A (2008) 1.58
A parent's point of view on the American Academy of Pediatrics policy statement: Children as hematopoietic stem cell donors. Pediatr Blood Cancer (2011) 1.52
ATRIP oligomerization is required for ATR-dependent checkpoint signaling. J Biol Chem (2005) 1.51
DNA damage response: three levels of DNA repair regulation. Cold Spring Harb Perspect Biol (2013) 1.48
Monitoring the spatiotemporal dynamics of proteins at replication forks and in assembled chromatin using isolation of proteins on nascent DNA. Nat Protoc (2012) 1.45
Incidence and outcome of chronic graft-versus-host disease using National Institutes of Health consensus criteria. Biol Blood Marrow Transplant (2007) 1.44
Identification of proteins at active, stalled, and collapsed replication forks using isolation of proteins on nascent DNA (iPOND) coupled with mass spectrometry. J Biol Chem (2013) 1.43
Substrate-selective repair and restart of replication forks by DNA translocases. Cell Rep (2013) 1.39
Functional genomic screens identify CINP as a genome maintenance protein. Proc Natl Acad Sci U S A (2009) 1.38
Cyclin-dependent kinase 9-cyclin K functions in the replication stress response. EMBO Rep (2010) 1.36
Outcomes of pediatric bone marrow transplantation for leukemia and myelodysplasia using matched sibling, mismatched related, or matched unrelated donors. Blood (2010) 1.33
Cyclin-dependent kinase 2 dependent phosphorylation of ATRIP regulates the G2-M checkpoint response to DNA damage. Cancer Res (2007) 1.27
Sensitivity to poly(ADP-ribose) polymerase (PARP) inhibition identifies ubiquitin-specific peptidase 11 (USP11) as a regulator of DNA double-strand break repair. J Biol Chem (2010) 1.26
Eph/ephrin profiling in human breast cancer reveals significant associations between expression level and clinical outcome. PLoS One (2011) 1.22
Busulfan/melphalan/antithymocyte globulin followed by unrelated donor cord blood transplantation for treatment of infant leukemia and leukemia in young children: the Cord Blood Transplantation study (COBLT) experience. Biol Blood Marrow Transplant (2005) 1.17
Thr-1989 phosphorylation is a marker of active ataxia telangiectasia-mutated and Rad3-related (ATR) kinase. J Biol Chem (2011) 1.16
Obesity does not preclude safe and effective myeloablative hematopoietic cell transplantation (HCT) for acute myelogenous leukemia (AML) in adults. Biol Blood Marrow Transplant (2010) 1.15
Use of G-CSF in matched sibling donor pediatric allogeneic transplantation: a consensus statement from the Children's Oncology Group (COG) Transplant Discipline Committee and Pediatric Blood and Marrow Transplant Consortium (PBMTC) Executive Committee. Pediatr Blood Cancer (2006) 1.13
Activation of ATR and related PIKKs. Cell Cycle (2008) 1.12
Comparison of pharmacokinetics and safety of voriconazole intravenous-to-oral switch in immunocompromised children and healthy adults. Antimicrob Agents Chemother (2011) 1.10
ATR and ATRIP are recruited to herpes simplex virus type 1 replication compartments even though ATR signaling is disabled. J Virol (2010) 1.07
Two novel CHS1 (LYST) mutations: clinical correlations in an infant with Chediak-Higashi syndrome. Mol Genet Metab (2005) 1.07
Hospice referral practices for children with cancer: a survey of pediatric oncologists. J Clin Oncol (2006) 1.04
HDAC3 is essential for DNA replication in hematopoietic progenitor cells. J Clin Invest (2013) 1.02
Comparison of outcomes after transplantation of G-CSF-stimulated bone marrow grafts versus bone marrow or peripheral blood grafts from HLA-matched sibling donors for patients with severe aplastic anemia. Biol Blood Marrow Transplant (2010) 1.01
SMARCAL1 and replication stress: an explanation for SIOD? Nucleus (2010) 1.01
Histone acetyl transferase 1 is essential for mammalian development, genome stability, and the processing of newly synthesized histones H3 and H4. PLoS Genet (2013) 0.99
Comparison of pharmacokinetics and safety of voriconazole intravenous-to-oral switch in immunocompromised adolescents and healthy adults. Antimicrob Agents Chemother (2011) 0.98
A role for CDK9-cyclin K in maintaining genome integrity. Cell Cycle (2011) 0.98
Discovery of a potent stapled helix peptide that binds to the 70N domain of replication protein A. J Med Chem (2014) 0.97
A phase II multicenter study of visilizumab, humanized anti-CD3 antibody, to treat steroid-refractory acute graft-versus-host disease. Biol Blood Marrow Transplant (2005) 0.94
Initial vancomycin dosing in pediatric oncology and stem cell transplant patients. J Pediatr Hematol Oncol (2009) 0.93
Inhibition of histone deacetylase 3 causes replication stress in cutaneous T cell lymphoma. PLoS One (2013) 0.93
Identification and characterization of SMARCAL1 protein complexes. PLoS One (2013) 0.93
Acute lymphoblastic leukemia. J Natl Compr Canc Netw (2012) 0.93
Function of the ATR N-terminal domain revealed by an ATM/ATR chimera. Exp Cell Res (2007) 0.92
Influenza immunization practices among pediatric oncologists. J Pediatr Hematol Oncol (2003) 0.92
Immune responses to influenza immunization in children receiving maintenance chemotherapy for acute lymphoblastic leukemia. Pediatr Blood Cancer (2004) 0.92
t(17;19) in Children with Acute Lymphocytic Leukemia: A Report of 3 Cases and a Review of the Literature. Case Rep Hematol (2013) 0.87
Risk adopted allogeneic hematopoietic stem cell transplantation using a reduced intensity regimen for children with thalassemia major. Pediatr Blood Cancer (2013) 0.87
A cord blood transplant recipient with Mycobacterium mucogenicum central venous catheter infection after infusion of tap water. Pediatr Infect Dis J (2006) 0.86
Rituximab resistant evans syndrome and autoimmunity in Schimke immuno-osseous dysplasia. Pediatr Rheumatol Online J (2011) 0.86
Allogeneic bone marrow transplantation for chemotherapy-refractory hepatosplenic gammadelta T-cell lymphoma: case report and review of the literature. J Pediatr Hematol Oncol (2005) 0.85
Improved outcome with immunosuppressive monotherapy after renal transplantation in Schimke-immuno-osseous dysplasia. Pediatr Transplant (2008) 0.84
Molecular analysis of the CYP21 gene and prenatal diagnosis in families with 21-hydroxylase deficiency in northeastern Iran. Horm Res (2005) 0.83
Childhood obesity and outcomes after bone marrow transplantation for patients with severe aplastic anemia. Biol Blood Marrow Transplant (2010) 0.83
New allergies after cord blood transplantation. Cytotherapy (2013) 0.82
Compound heterozygous c-Mpl mutations in a child with congenital amegakaryocytic thrombocytopenia: functional characterization and a review of the literature. Exp Hematol (2009) 0.82
Analysis of mutations that dissociate G(2) and essential S phase functions of human ataxia telangiectasia-mutated and Rad3-related (ATR) protein kinase. J Biol Chem (2011) 0.82
Hematopoietic stem cell transplantation for children with primary immunodeficiency diseases: single center experience in Jordan. Pediatr Transplant (2013) 0.82
Purification of proteins on newly synthesized DNA using iPOND. Methods Mol Biol (2015) 0.81
Autoimmune hemolytic anemia with giant cell hepatitis: case report and review of the literature. J Pediatr Hematol Oncol (2004) 0.81
Incidence, risk factors, and outcome of pneumatosis intestinalis in pediatric stem cell transplant recipients. Pediatr Blood Cancer (2011) 0.81
Heart transplant survival outcomes for adriamycin-dilated cardiomyopathy. Am J Cardiol (2012) 0.80
A case of pediatric PTLD following autologous stem cell transplantation and review of the literature. Pediatr Transplant (2010) 0.80
Risk of subsequent malignancies in survivors of childhood leukemia. J Cancer Surviv (2013) 0.80
Less could be better: the case for reducing the dose of cyclophosphamide for children undergoing allogeneic stem cell transplant for severe aplastic anemia. Pediatr Transplant (2013) 0.80
Two novel mutations in CYP11B1 and modeling the consequent alterations of the translated protein in classic congenital adrenal hyperplasia patients. Endocrine (2013) 0.79
Phosphorylation of a C-terminal auto-inhibitory domain increases SMARCAL1 activity. Nucleic Acids Res (2013) 0.79
SOSS1/2: Sensors of single-stranded DNA at a break. Mol Cell (2009) 0.78
Allogeneic hematopoietic stem cell transplantation for infants with idiopathic myelofibrosis. Pediatr Transplant (2013) 0.78
Advancement of pediatric blood and marrow transplantation research in North America: priorities of the Pediatric Blood and Marrow Transplant Consortium. Biol Blood Marrow Transplant (2010) 0.78
Bone marrow transplantation in phosphoglycerate kinase (PGK) deficiency. Br J Haematol (2011) 0.78
Non-hodgkin lymphoma in a child with schimke immuno-osseous dysplasia. Iran J Med Sci (2011) 0.77
Human rhinovirus C infections in pediatric hematology and oncology patients. Pediatr Transplant (2014) 0.77
Safety of high dose trivalent inactivated influenza vaccine in pediatric patients with acute lymphoblastic leukemia. Pediatr Blood Cancer (2013) 0.77
Novel mutation in the SLC19A2 gene in an Iranian family with thiamine-responsive megaloblastic anemia: a series of three cases. J Clin Res Pediatr Endocrinol (2013) 0.77
Prolonged fever and splenic lesions caused by Malassezia restricta in an immunocompromised patient. Pediatr Transplant (2014) 0.77
Defining genome maintenance pathways using functional genomic approaches. Crit Rev Biochem Mol Biol (2011) 0.77
Comparison of pre-cryopreserved and post-thaw-and-wash-nucleated cell count on major outcomes following unrelated cord blood transplant in children. Pediatr Transplant (2012) 0.76
Safety and efficacy of a continuous infusion, patient-controlled antiemetic pump for children receiving emetogenic chemotherapy. Pediatr Blood Cancer (2007) 0.76
Early lymphocyte reconstitution is associated with improved transplant outcome after cord blood transplantation. Cytotherapy (2010) 0.76
Effects of Race/Ethnicity and Socioeconomic Status on Outcome in Childhood Acute Lymphoblastic Leukemia. J Pediatr Hematol Oncol (2016) 0.76
Unrelated stem cell transplant for infantile idiopathic myelofibrosis. Pediatr Blood Cancer (2009) 0.76
The quality of privately banked cord blood. Pediatr Blood Cancer (2011) 0.75
Severe ehrlichia infection in pediatric oncology and stem cell transplant patients. Pediatr Blood Cancer (2010) 0.75
Etanercept for treatment of idiopathic pneumonia syndrome after allogeneic hematopoietic stem cell transplantation. Blood (2009) 0.75
Erratum: Replication fork stability confers chemoresistance in BRCA-deficient cells. Nature (2016) 0.75
Castleman disease in a pediatric liver transplant recipient: a case report and literature review. Pediatr Transplant (2011) 0.75
Incidence and risk factors for cytomegalovirus (CMV) reactivation following autologous hematopoietic stem cell transplantation in children. Pediatr Blood Cancer (2014) 0.75